Literature DB >> 18210152

Establishment of thymoma-prone congenic rat strain, ACI.BUF/Mna-Tsr1/Tsr1.

Mutsushi Matsuyama1, Kazuo Kato, Kyoko Higo-Moriguchi, Tetsuji Yamada, Takashi Kuramoto, Makoto Kuroda.   

Abstract

PURPOSE: To confirm the presence of the susceptible gene for the thymoma development in the region that was assumed by the previous linkage study by Oyabu et al. (J Natl Cancer Inst 91:279-282, 1999), we tried to establish a congenic strain of rats.
METHODS: Backcrossings between the BUF/Mna strain as a donor strain and the ACI/NMna strain as an inbred partner were repeated for 12 generations, examining whether rats had the thymoma development region, and then homozygous rats were yielded by mating among the heterozygotes. To detect the phenotypic expression, heterozygous ACI.BUF/Mna-Tsr1/+ (ACI-Tsr1/+) rats were generated by crossing female ACI.BUF/Mna-Tsr1/Tsr1 (ACI-Tsr1/Tsr1) rats with male ACI/NMna rats and were maintained for 24 months.
RESULTS: These ACI-Tsr1/+ rats produced thymoma in 71%, showing a dominant trait. The thymomas were of the lymphocyte predominant type, as those developed in rats of the original BUF/Mna strain.
CONCLUSIONS: Thus, a new rat congenic strain, ACI-Tsr1/Tsr1, was established, revealing that thymoma develops in the dominant trait in ACI-Tsr1/+ rats.

Entities:  

Mesh:

Year:  2008        PMID: 18210152     DOI: 10.1007/s00432-007-0346-2

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  13 in total

1.  Genetic mapping of the thymoma susceptible locus, Tsr1, in BUF/Mna rats.

Authors:  A Oyabu; K Higo; C Ye; H Amo; M Saito; S Yagyu; H Morita; K Maeda; T Serikawa; M Takahashi; M Matsuyama
Journal:  J Natl Cancer Inst       Date:  1999-02-03       Impact factor: 13.506

2.  A single dominant susceptible gene determines spontaneous development of thymoma in BUF/Mna rat.

Authors:  M Matsuyama; C Yamada; H Hiai
Journal:  Jpn J Cancer Res       Date:  1986-11

Review 3.  A comparative genetic map of rat, mouse and human genomes.

Authors:  T Serikawa; Z Cui; N Yokoi; T Kuramoto; Y Kondo; K Kitada; J L Guénet
Journal:  Exp Anim       Date:  1998-01

4.  Generation of a polymorphic marker linked to thymoma susceptibility gene of rat 1 by genetically-directed representational difference analysis.

Authors:  K Higo; T Ushijima; A Oyabu; C Ye; S Yagyu; H Takahashi; M Matsuyama
Journal:  Exp Anim       Date:  2000-07

5.  Strain difference in carcinogenesis by urethan administration to suckling rats.

Authors:  M Matsuyama; H Suzuki; M Ito; S Yamada; T Nagayo
Journal:  Gan       Date:  1972-04

6.  Spontaneous thyoma in Buffalo rats.

Authors:  S Yamada; K Masuko; M Ito; T Nagayo
Journal:  Gan       Date:  1973-06

7.  Mapping of two genetic loci, Ten-1 and Ten-2, associated with thymus enlargement in BUF/Mna rats.

Authors:  Y Murakumo; M Takahashi; N Sharma; A Arakawa; M Saito; H Amo; M Matsuyama
Journal:  Mamm Genome       Date:  1996-07       Impact factor: 2.957

8.  Ultrastructure of spontaneous and urethan-induced thymomas in buffalo rats.

Authors:  M Matsuyama; H Suzuki; S Yamada; M Ito; T Nagayo
Journal:  Cancer Res       Date:  1975-10       Impact factor: 12.701

9.  Correlating genetic aberrations with World Health Organization-defined histology and stage across the spectrum of thymomas.

Authors:  Masayoshi Inoue; Petr Starostik; Andreas Zettl; Philipp Ströbel; Stephan Schwarz; Francesco Scaravilli; Kristin Henry; Nick Willcox; Hans-Konrad Müller-Hermelink; Alexander Marx
Journal:  Cancer Res       Date:  2003-07-01       Impact factor: 12.701

10.  An intrinsic thymic epithelial abnormality is responsible for the spontaneous development of predominantly lymphocytic thymomas in BUF/Mna rats.

Authors:  O Taguchi; K Kontani; H Ikeda; M Matsuyama
Journal:  Jpn J Cancer Res       Date:  1992-11
View more
  1 in total

1.  Congenic strain differences of renal malformations in ACI/Mna rats by introgression of the chromosomal region of BUF/Mna rats containing Pur1.

Authors:  Mutsushi Matsuyama; Chiemi Haneda; Kazuo Kato
Journal:  Nagoya J Med Sci       Date:  2013-08       Impact factor: 1.131

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.